Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Clinical Medicine
|
February 5, 2021
Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren's Syndrome
Erika Huijser, Marjan A Versnel
Clinical Chemistry and Laboratory Medicine
|
October 14, 2025
Cross reactivity of endogenous and exogenous 25-hydroxyvitamin D<sub>2</sub> in commercial vitamin D assays; an evaluation using the Dutch external quality assessment scheme
Erika Huijser, Judith A P Bons, Annemieke C Heijboer
Clinical Chemistry
|
December 12, 2024
"Fireworks" in Fatty Urine
Jorik H Amesz, Erika Huijser, Rob F M Bevers, et al.
Frontiers in Immunology
|
April 4, 2022
Genetic Variants of the <i>BAFF</i> Gene and Risk of Fatigue Among Patients With Primary Sjögren's Syndrome
Christina-Maria Flessa, Evangelia Zampeli, Maria-Eleftheria Evangelopoulos, et al.
Clinical & Translational Immunology
|
October 22, 2020
Inverse correlation between serum complement component C1q levels and whole blood type-1 interferon signature in active tuberculosis and QuantiFERON-positive uveitis: implications for diagnosis
Benjamin Schrijver, Douwe J Dijkstra, Nicole V Borggreven, et al.
Rheumatology (Oxford, England)
|
September 10, 2021
Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren's syndrome
Erika Huijser, Jens Göpfert, Zana Brkic, et al.
Journal of Autoimmunity
|
April 21, 2018
TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis
Iris L A Bodewes, Erika Huijser, Cornelia G van Helden-Meeuwsen, et al.
Rheumatology (Oxford, England)
|
December 14, 2022
Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort
M Javad Wahadat, Hongchao Qi, Cornelia G van Helden-Meeuwsen, et al.
Frontiers in Oncology
|
April 10, 2023
Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren's syndrome patients through immunogenetics
P Martijn Kolijn, Erika Huijser, M Javad Wahadat, et al.
Rheumatology (Oxford, England)
|
March 18, 2019
MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis
Erika Huijser, Cornelia G van Helden-Meeuwsen, Noortje Groot, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Clinical Medicine
|
February 5, 2021
Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren's Syndrome
Erika Huijser, Marjan A Versnel
Clinical Chemistry and Laboratory Medicine
|
October 14, 2025
Cross reactivity of endogenous and exogenous 25-hydroxyvitamin D<sub>2</sub> in commercial vitamin D assays; an evaluation using the Dutch external quality assessment scheme
Erika Huijser, Judith A P Bons, Annemieke C Heijboer
Clinical Chemistry
|
December 12, 2024
"Fireworks" in Fatty Urine
Jorik H Amesz, Erika Huijser, Rob F M Bevers, et al.
Frontiers in Immunology
|
April 4, 2022
Genetic Variants of the <i>BAFF</i> Gene and Risk of Fatigue Among Patients With Primary Sjögren's Syndrome
Christina-Maria Flessa, Evangelia Zampeli, Maria-Eleftheria Evangelopoulos, et al.
Clinical & Translational Immunology
|
October 22, 2020
Inverse correlation between serum complement component C1q levels and whole blood type-1 interferon signature in active tuberculosis and QuantiFERON-positive uveitis: implications for diagnosis
Benjamin Schrijver, Douwe J Dijkstra, Nicole V Borggreven, et al.
Rheumatology (Oxford, England)
|
September 10, 2021
Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren's syndrome
Erika Huijser, Jens Göpfert, Zana Brkic, et al.
Journal of Autoimmunity
|
April 21, 2018
TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis
Iris L A Bodewes, Erika Huijser, Cornelia G van Helden-Meeuwsen, et al.
Rheumatology (Oxford, England)
|
December 14, 2022
Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort
M Javad Wahadat, Hongchao Qi, Cornelia G van Helden-Meeuwsen, et al.
Frontiers in Oncology
|
April 10, 2023
Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren's syndrome patients through immunogenetics
P Martijn Kolijn, Erika Huijser, M Javad Wahadat, et al.
Rheumatology (Oxford, England)
|
March 18, 2019
MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis
Erika Huijser, Cornelia G van Helden-Meeuwsen, Noortje Groot, et al.
Page
of 2